TreeWAS – Variant ID: rs13007495

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K50.1 Crohn's disease of large intestine	0.018	0.982	0.000
C45.0 Mesothelioma of pleura	0.017	0.983	0.000
C45 Mesothelioma	0.016	0.984	0.000
C45.7 Mesothelioma of other sites	0.015	0.985	0.000
C45.9 Mesothelioma, unspecified	0.015	0.985	0.000
K58.9 Irritable bowel syndrome without diarrhoea	0.000	0.988	0.012
C45.2 Mesothelioma of pericardium	0.012	0.988	0.000
C45.1 Mesothelioma of peritoneum	0.012	0.988	0.000
M13.99 Arthritis, unspecified (Site unspecified)	0.000	0.989	0.011
K50 Crohn's disease [regional enteritis]	0.010	0.990	0.000
K50.9 Crohn's disease, unspecified	0.008	0.992	0.000
K50.8 Other Crohn's disease	0.008	0.992	0.000
K50.0 Crohn's disease of small intestine	0.008	0.992	0.000
K58 Irritable bowel syndrome	0.000	0.994	0.006
Z08.8 Follow-up examination after other treatment for malignant neoplasm	0.005	0.995	0.000
J38.7 Other diseases of larynx	0.000	0.995	0.005
K58.0 Irritable bowel syndrome with diarrhoea	0.000	0.995	0.005
K37 Unspecified appendicitis	0.005	0.995	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.005	0.995	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.005	0.995	0.000
R04.0 Epistaxis	0.004	0.996	0.000
Z08.0 Follow-up examination after surgery for malignant neoplasm	0.004	0.996	0.000
I95.1 Orthostatic hypotension	0.004	0.996	0.000
C49 Malignant neoplasm of other connective and soft tissue	0.004	0.996	0.000
I31.3 Pericardial effusion (noninflammatory)	0.004	0.996	0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.003	0.996	0.000
C46 Kaposi's sarcoma	0.003	0.996	0.000
Z30.5 Surveillance of (intra-uterine) contraceptive device	0.000	0.996	0.004
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm	0.004	0.996	0.000
Z08 Follow-up examination after treatment for malignant neoplasm	0.004	0.996	0.000
J37.0 Chronic laryngitis	0.000	0.996	0.004
C49.6 Connective and soft tissue of trunk, unspecified	0.003	0.997	0.000
M54.49 Lumbago with sciatica (Site unspecified)	0.003	0.997	0.000
C49.3 Connective and soft tissue of thorax	0.003	0.997	0.000
C49.9 Connective and soft tissue, unspecified	0.003	0.997	0.000
J38.4 Oedema of larynx	0.000	0.997	0.003
J38.1 Polyp of vocal cord and larynx	0.000	0.997	0.003
W49.9 Unspecified place	0.003	0.997	0.000
J38 Diseases of vocal cords and larynx, not elsewhere classified	0.000	0.997	0.003
C49.8 Overlapping lesion of connective and soft tissue	0.003	0.997	0.000
C49.5 Connective and soft tissue of pelvis	0.003	0.997	0.000
C49.4 Connective and soft tissue of abdomen	0.003	0.997	0.000
C46.9 Kaposi's sarcoma, unspecified	0.003	0.997	0.000
C46.8 Kaposi's sarcoma of multiple organs	0.003	0.997	0.000
C46.7 Kaposi's sarcoma of other sites	0.003	0.997	0.000
C46.3 Kaposi's sarcoma of lymph nodes	0.003	0.997	0.000
C46.2 Kaposi's sarcoma of palate	0.003	0.997	0.000
C46.1 Kaposi's sarcoma of soft tissue	0.003	0.997	0.000
C46.0 Kaposi's sarcoma of skin	0.003	0.997	0.000
C47.9 Peripheral nerves and autonomic nervous system, unspecified	0.003	0.997	0.000
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system	0.003	0.997	0.000
C47.6 Peripheral nerves of trunk, unspecified	0.003	0.997	0.000
C47.5 Peripheral nerves of pelvis	0.003	0.997	0.000
C47.4 Peripheral nerves of abdomen	0.003	0.997	0.000
C47.3 Peripheral nerves of thorax	0.003	0.997	0.000
C47.2 Peripheral nerves of lower limb, including hip	0.003	0.997	0.000
C47.1 Peripheral nerves of upper limb, including shoulder	0.003	0.997	0.000
C47.0 Peripheral nerves of head, face and neck	0.003	0.997	0.000
C49.1 Connective and soft tissue of upper limb, including shoulder	0.003	0.997	0.000
Z08.1 Follow-up examination after radiotherapy for malignant neoplasm	0.003	0.997	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.997	0.003
J38.2 Nodules of vocal cords	0.000	0.997	0.003
Y60.0 During surgical operation	0.000	0.997	0.003
Z86.3 Personal history of endocrine, nutritional and metabolic diseases	0.003	0.997	0.000
C49.2 Connective and soft tissue of lower limb, including hip	0.002	0.997	0.000
C49.0 Connective and soft tissue of head, face and neck	0.002	0.997	0.000
Z39.0 Care and examination immediately after delivery	0.000	0.997	0.003
R93.5 Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum	0.003	0.997	0.000
M89.98 Disorder of bone, unspecified (Other)	0.002	0.998	0.000
R02 Gangrene, not elsewhere classified	0.002	0.998	0.000
H40.2 Primary angle-closure glaucoma	0.002	0.998	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.998	0.002
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.002	0.998	0.000
J38.6 Stenosis of larynx	0.000	0.998	0.002
Z39.1 Care and examination of lactating mother	0.000	0.998	0.002
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand	0.002	0.998	0.000
M65.34 Trigger finger-Hand	0.000	0.998	0.002
I27.2 Other secondary pulmonary hypertension	0.002	0.998	0.000
D16.4 Bones of skull and face	0.000	0.998	0.002
Z89.4 Acquired absence of foot and ankle	0.002	0.998	0.000
M65.14 Other infective (teno)synovitis (Hand)	0.000	0.998	0.002
H92.0 Otalgia	0.002	0.998	0.000
J38.5 Laryngeal spasm	0.000	0.998	0.002
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.002	0.998	0.000
H47.3 Other disorders of optic disk	0.002	0.998	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
F17.1 Harmful use	0.000	0.998	0.002
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.998	0.002
Z39 Postpartum care and examination	0.000	0.998	0.002
M23.24 Derangement of meniscus due to old tear or injury (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.000	0.998	0.002
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
M65.44 Radial styloid tenosynovitis [de Quervain] (Hand)	0.000	0.998	0.002
M65.3 Trigger finger	0.000	0.998	0.002
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
I83.1 Varicose veins of lower extremities with inflammation	0.000	0.998	0.002
M65.4 Radial styloid tenosynovitis [de Quervain]	0.000	0.998	0.002
N64.1 Fat necrosis of breast	0.002	0.998	0.000
M65.86 Other synovitis and tenosynovitis (Lower leg)	0.000	0.998	0.002
M65.1 Other infective (teno)synovitis	0.000	0.998	0.002
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
M65.43 Radial styloid tenosynovitis [de Quervain] (Forearm)	0.000	0.998	0.002
M89.95 Disorder of bone, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
C48.1 Specified parts of peritoneum	0.001	0.998	0.000
D25.1 Intramural leiomyoma of uterus	0.000	0.998	0.002
M89.06 Algoneurodystrophy (Lower leg)	0.002	0.998	0.000
Z08.7 Follow-up examination after combined treatment for malignant neoplasm	0.002	0.998	0.000
Z99.2 Dependence on renal dialysis	0.002	0.998	0.000
H43.1 Vitreous haemorrhage	0.002	0.998	0.000
M89.9 Disorder of bone, unspecified	0.002	0.998	0.000
C48.0 Retroperitoneum	0.001	0.998	0.000
C43.7 Malignant melanoma of lower limb, including hip	0.000	0.998	0.002
Z39.2 Routine postpartum follow-up	0.000	0.998	0.002
N50.8 Other specified disorders of male genital organs	0.000	0.998	0.002
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.002
W49 Exposure to other and unspecified inanimate mechanical forces	0.002	0.998	0.000
I38 Endocarditis, valve unspecified	0.000	0.998	0.002
M65.39 Trigger finger-Site unspec	0.000	0.998	0.001
M65.38 Trigger finger-Other	0.000	0.998	0.001
M65.37 Trigger finger-Ankle/foot	0.000	0.998	0.001
M65.36 Trigger finger-Lower leg	0.000	0.998	0.001
M65.35 Trigger finger-Pelvic/thigh	0.000	0.998	0.001
M65.33 Trigger finger-Forearm	0.000	0.998	0.001
M65.32 Trigger finger-Upper arm	0.000	0.998	0.001
M65.31 Trigger finger-Shldr region	0.000	0.998	0.001
M65.30 Trigger finger-Mult sites	0.000	0.998	0.001
Z03.1 Observation for suspected malignant neoplasm	0.000	0.998	0.002
M72.0 Palmar fascial fibromatosis [Dupuytren]	0.002	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.001	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.001	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.001	0.998	0.000
J37 Chronic laryngitis and laryngotracheitis	0.000	0.998	0.002
M65 Synovitis and tenosynovitis	0.000	0.998	0.002
M65.49 Radial styloid tenosynovitis [de Quervain]-Site unspec	0.000	0.998	0.001
M65.48 Radial styloid tenosynovitis [de Quervain]-Other	0.000	0.998	0.001
M65.47 Radial styloid tenosynovitis [de Quervain]-Ankle/foot	0.000	0.998	0.001
M65.46 Radial styloid tenosynovitis [de Quervain]-Lower leg	0.000	0.998	0.001
M65.45 Radial styloid tenosynovitis [de Quervain]-Pelvic/thigh	0.000	0.998	0.001
M65.42 Radial styloid tenosynovitis [de Quervain]-Upper arm	0.000	0.998	0.001
M65.41 Radial styloid tenosynovitis [de Quervain]-Shldr region	0.000	0.998	0.001
M65.40 Radial styloid tenosynovitis [de Quervain] (Multiple sites)	0.000	0.998	0.001
M89.92 Disorder of bone, unspecified (Upper arm)	0.001	0.998	0.000
S02.30 Fracture of orbital floor (closed)	0.002	0.998	0.000
M89.96 Disorder of bone, unspecified (Lower leg)	0.001	0.998	0.000
M65.8 Other synovitis and tenosynovitis	0.000	0.998	0.002
M65.19 Other infective (teno)synovitis (Site unspecified)	0.000	0.998	0.001
M65.18 Other infective (teno)synovitis (Other)	0.000	0.998	0.001
M65.17 Other infective (teno)synovitis (Ankle and foot)	0.000	0.998	0.001
M65.16 Other infective (teno)synovitis (Lower leg)	0.000	0.998	0.001
M65.15 Other infective (teno)synovitis (Pelvic region and thigh)	0.000	0.998	0.001
M65.13 Other infective (teno)synovitis (Forearm)	0.000	0.998	0.001
M65.12 Other infective (teno)synovitis (Upper arm)	0.000	0.998	0.001
M65.11 Other infective (teno)synovitis (Shoulder region)	0.000	0.998	0.001
M65.10 Other infective (teno)synovitis (Multiple sites)	0.000	0.998	0.001
M72.09 Palmar fascial fibromatosis [Dupuytren]-Site unspec	0.001	0.998	0.000
J38.3 Other diseases of vocal cords	0.000	0.998	0.002
J38.0 Paralysis of vocal cords and larynx	0.000	0.998	0.001
M89.0 Algoneurodystrophy	0.002	0.998	0.000
M24.16 Other articular cartilage disorders (Lower leg)	0.000	0.998	0.002
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.001
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
Z29.2 Other prophylactic chemotherapy	0.002	0.998	0.000
M89.99 Disorder of bone, unspecified (Site unspecified)	0.001	0.998	0.000
M89.93 Disorder of bone, unspecified (Forearm)	0.001	0.998	0.000
M89.91 Disorder of bone, unspecified (Shoulder region)	0.001	0.998	0.000
M89.90 Disorder of bone, unspecified (Multiple sites)	0.001	0.998	0.000
C48.2 Peritoneum, unspecified	0.001	0.998	0.001
M25.76 Osteophyte (Lower leg)	0.000	0.998	0.002
M23.32 Other meniscus derangements (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.000	0.998	0.002
W49.8 Other specified place	0.001	0.998	0.000
W49.7 Farm	0.001	0.998	0.000
W49.6 Industrial and construction area	0.001	0.998	0.000
W49.5 Trade and service area	0.001	0.998	0.000
W49.4 Street and highway	0.001	0.998	0.000
W49.3 Sports and athletics area	0.001	0.998	0.000
W49.2 School, other institution and public administrative area	0.001	0.998	0.000
W49.1 Residential institution	0.001	0.998	0.000
M89.04 Algoneurodystrophy (Hand)	0.001	0.999	0.000
M89.94 Disorder of bone, unspecified (Hand)	0.001	0.999	0.000
C92.0 Acute myeloid leukaemia	0.001	0.999	0.000
Y42.7 Androgens and anabolic congeners	0.001	0.999	0.000
Y54.3 Benzothiadiazine derivatives	0.001	0.999	0.000
I27.0 Primary pulmonary hypertension	0.001	0.999	0.000
M65.2 Calcific tendinitis	0.000	0.999	0.001
M65.0 Abscess of tendon sheath	0.000	0.999	0.001
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.000	0.999	0.001
M72.08 Palmar fascial fibromatosis [Dupuytren]-Other	0.001	0.999	0.000
M72.07 Palmar fascial fibromatosis [Dupuytren]-Ankle/Foot	0.001	0.999	0.000
M72.06 Palmar fascial fibromatosis [Dupuytren]-Lower Leg	0.001	0.999	0.000
M72.05 Palmar fascial fibromatosis [Dupuytren]-Pelvic/Thigh	0.001	0.999	0.000
M72.03 Palmar fascial fibromatosis [Dupuytren]-Forearm	0.001	0.999	0.000
M72.02 Palmar fascial fibromatosis [Dupuytren]-Upper arm	0.001	0.999	0.000
M72.01 Palmar fascial fibromatosis [Dupuytren]-Shldr region	0.001	0.999	0.000
M72.00 Palmar fascial fibromatosis [Dupuytren]-Mult sites	0.001	0.999	0.000
M89.07 Algoneurodystrophy (Ankle and foot)	0.001	0.999	0.000
J37.1 Chronic laryngotracheitis	0.000	0.999	0.001
Z42.1 Follow-up care involving plastic surgery of breast	0.001	0.999	0.000
M65.89 Other synovitis and tenosynovitis (Site unspecified)	0.000	0.999	0.001
M65.88 Other synovitis and tenosynovitis (Other)	0.000	0.999	0.001
M65.85 Other synovitis and tenosynovitis (Pelvic region and thigh)	0.000	0.999	0.001
M65.82 Other synovitis and tenosynovitis (Upper arm)	0.000	0.999	0.001
M65.80 Other synovitis and tenosynovitis (Multiple sites)	0.000	0.999	0.001
Y42.5 Other oestrogens and progestogens	0.001	0.999	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.001	0.999	0.000
Y57.9 Drug or medicament, unspecified	0.001	0.999	0.000
M89.08 Algoneurodystrophy (Other)	0.001	0.999	0.000
M89.05 Algoneurodystrophy (Pelvic region and thigh)	0.001	0.999	0.000
M89.02 Algoneurodystrophy (Upper arm)	0.001	0.999	0.000
M89.01 Algoneurodystrophy (Shoulder region)	0.001	0.999	0.000
M89.00 Algoneurodystrophy (Multiple sites)	0.001	0.999	0.000
H10.9 Conjunctivitis, unspecified	0.001	0.999	0.000
M65.81 Other synovitis and tenosynovitis (Shoulder region)	0.000	0.999	0.001
M89.09 Algoneurodystrophy (Site unspecified)	0.001	0.999	0.000
H57.8 Other specified disorders of eye and adnexa	0.001	0.999	0.000
M96.0 Pseudarthrosis after fusion or arthrodesis	0.001	0.999	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.001	0.999	0.000
Y46.7 Anti-Parkinsonism drugs	0.001	0.999	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.001	0.999	0.000
I27 Other pulmonary heart diseases	0.001	0.999	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.001	0.999	0.000
F10.3 Withdrawal state	0.000	0.999	0.001
Y60.4 During endoscopic examination	0.000	0.999	0.001
M65.87 Other synovitis and tenosynovitis (Ankle and foot)	0.000	0.999	0.001
M65.83 Other synovitis and tenosynovitis (Forearm)	0.000	0.999	0.001
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.001	0.999	0.000
E28.2 Polycystic ovarian syndrome	0.001	0.999	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.001	0.999	0.000
M90.78 Fracture of bone in neoplastic disease (Other)	0.001	0.999	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.001	0.999	0.000
Y60.9 During unspecified surgical and medical care	0.000	0.999	0.001
Y60.7 During administration of enema	0.000	0.999	0.001
Y60.6 During aspiration, puncture and other catheterisation	0.000	0.999	0.001
Y60.5 During heart catheterisation	0.000	0.999	0.001
Y60.3 During injection or immunisation	0.000	0.999	0.001
Y60.2 During kidney dialysis or other perfusion	0.000	0.999	0.001
Y60.1 During infusion or transfusion	0.000	0.999	0.001
M89 Other disorders of bone	0.001	0.999	0.000
M65.09 Abscess of tendon sheath (Site unspecified)	0.000	0.999	0.001
M65.08 Abscess of tendon sheath (Other)	0.000	0.999	0.001
M65.07 Abscess of tendon sheath (Ankle and foot)	0.000	0.999	0.001
M65.06 Abscess of tendon sheath (Lower leg)	0.000	0.999	0.001
M65.05 Abscess of tendon sheath (Pelvic region and thigh)	0.000	0.999	0.001
M65.04 Abscess of tendon sheath (Hand)	0.000	0.999	0.001
M65.03 Abscess of tendon sheath (Forearm)	0.000	0.999	0.001
M65.02 Abscess of tendon sheath (Upper arm)	0.000	0.999	0.001
M65.01 Abscess of tendon sheath (Shoulder region)	0.000	0.999	0.001
M65.00 Abscess of tendon sheath (Multiple sites)	0.000	0.999	0.001
M65.29 Calcific tendinitis (Site unspecified)	0.000	0.999	0.001
M65.28 Calcific tendinitis (Other)	0.000	0.999	0.001
M65.27 Calcific tendinitis (Ankle and foot)	0.000	0.999	0.001
M65.26 Calcific tendinitis (Lower leg)	0.000	0.999	0.001
M65.25 Calcific tendinitis (Pelvic region and thigh)	0.000	0.999	0.001
M65.24 Calcific tendinitis (Hand)	0.000	0.999	0.001
M65.23 Calcific tendinitis (Forearm)	0.000	0.999	0.001
M65.22 Calcific tendinitis (Upper arm)	0.000	0.999	0.001
M65.21 Calcific tendinitis (Shoulder region)	0.000	0.999	0.001
M65.20 Calcific tendinitis (Multiple sites)	0.000	0.999	0.001
M65.84 Other synovitis and tenosynovitis (Hand)	0.000	0.999	0.001
M89.03 Algoneurodystrophy (Forearm)	0.001	0.999	0.000
W24.9 Unspecified place	0.001	0.999	0.000
U88 Agent resistant to multiple antibiotics	0.001	0.999	0.000
H92.1 Otorrhoea	0.001	0.999	0.000
J31.0 Chronic rhinitis	0.001	0.999	0.000
W49.0 Home	0.001	0.999	0.000
Y42.9 Other and unspecified hormone antagonists	0.001	0.999	0.000
Y42.4 Oral contraceptives	0.001	0.999	0.000
Y42.2 Antithyroid drugs	0.001	0.999	0.000
Y42.1 Thyroid hormones and substitutes	0.001	0.999	0.000
Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm	0.001	0.999	0.000
Y44 Agents primarily affecting blood constituents	0.001	0.999	0.000
M54.47 Lumbago with sciatica (Lumbosacral region)	0.001	0.999	0.000
I27.1 Kyphoscoliotic heart disease	0.001	0.999	0.000
M67.8 Other specified disorders of synovium and tendon	0.000	0.999	0.001
Y49.5 Other antipsychotics and neuroleptics	0.001	0.999	0.000
C92.7 Other myeloid leukaemia	0.001	0.999	0.000
I27.9 Pulmonary heart disease, unspecified	0.001	0.999	0.000
J31.1 Chronic nasopharyngitis	0.001	0.999	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.001	0.999	0.000
Y46.6 Other and unspecified antiepileptics	0.001	0.999	0.000
B37.7 Candidal septicaemia	0.001	0.999	0.000
M89.6 Osteopathy after poliomyelitis	0.001	0.999	0.000
M89.4 Other hypertrophic osteo-arthropathy	0.001	0.999	0.000
M89.2 Other disorders of bone development and growth	0.001	0.999	0.000
M89.1 Epiphyseal arrest	0.001	0.999	0.000
S66.9 Injury of unspecified muscle and tendon at wrist and hand level	0.001	0.999	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.001	0.999	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.001	0.999	0.000
Y54.9 Mineral salts, not elsewhere classified	0.001	0.999	0.000
Y54.7 Agents affecting calcification	0.001	0.999	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.001	0.999	0.000
Y54.5 Other diuretics	0.001	0.999	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.001	0.999	0.000
Y54.0 Mineralocorticoids	0.001	0.999	0.000
Y57.8 Other drugs and medicaments	0.001	0.999	0.000
H92 Otalgia and effusion of ear	0.001	0.999	0.000
Y57 Other and unspecified drugs and medicaments	0.001	0.999	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.001	0.999	0.000
M13.98 Arthritis, unspecified (Other)	0.001	0.999	0.000
M70.65 Trochanteric bursitis-Pelvic/Thigh	0.001	0.999	0.000
C92.1 Chronic myeloid leukaemia	0.001	0.999	0.000
D16.1 Short bones of upper limb	0.000	0.999	0.001
M54.4 Lumbago with sciatica	0.001	0.999	0.000
M89.3 Hypertrophy of bone	0.001	0.999	0.000
S46.2 Injury of muscle and tendon of other parts of biceps	0.001	0.999	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.001	0.999	0.000
S62.20 Fracture of first metacarpal bone (closed)	0.001	0.999	0.000
B00.1 Herpesviral vesicular dermatitis	0.000	0.999	0.001
Y48.3 Local anaesthetics	0.001	0.999	0.000
Y48.2 Other and unspecified general anaesthetics	0.001	0.999	0.000
Y54.4 Loop [high-ceiling] diuretics	0.001	0.999	0.000
Y48 Anaesthetics and therapeutic gases	0.001	0.999	0.000
M89.38 Hypertrophy of bone (Other)	0.001	0.999	0.000
D16.3 Short bones of lower limb	0.000	0.999	0.001
H10.4 Chronic conjunctivitis	0.001	0.999	0.000
I79.2 Peripheral angiopathy in diseases classified elsewhere	0.001	0.999	0.000
M89.5 Osteolysis	0.001	0.999	0.000
T82.4 Mechanical complication of vascular dialysis catheter	0.001	0.999	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.001	0.999	0.000
Y44.7 Plasma substitutes	0.001	0.999	0.000
Y44.6 Natural blood and blood products	0.001	0.999	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.001	0.999	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.001	0.999	0.000
Y60.8 During other surgical and medical care	0.000	0.999	0.001
M67 Other disorders of synovium and tendon	0.000	0.999	0.001
H81.2 Vestibular neuronitis	0.001	0.999	0.000
H92.2 Otorrhagia	0.001	0.999	0.000
I44.2 Atrioventricular block, complete	0.001	0.999	0.000
R59.9 Enlarged lymph nodes, unspecified	0.000	0.999	0.001
T43.2 Other and unspecified antidepressants	0.000	0.999	0.001
Y57.7 Vitamins, not elsewhere classified	0.001	0.999	0.000
Y57.6 Other diagnostic agents	0.001	0.999	0.000
Y57.4 Pharmaceutical excipients	0.001	0.999	0.000
Y57.3 Alcohol deterrents	0.001	0.999	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.001	0.999	0.000
Y57.1 Lipotropic drugs	0.001	0.999	0.000
Y57.0 Appetite depressants [anorectics]	0.001	0.999	0.000
Z50.0 Cardiac rehabilitation	0.001	0.999	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
M54.48 Lumbago with sciatica (Sacral and sacrococcygeal region)	0.001	0.999	0.000
M54.45 Lumbago with sciatica (Thoracolumbar region)	0.001	0.999	0.000
M54.44 Lumbago with sciatica-Thoracic	0.001	0.999	0.000
M54.43 Lumbago with sciatica-Cervicothoracic	0.001	0.999	0.000
M54.42 Lumbago with sciatica-Cervical	0.001	0.999	0.000
M54.41 Lumbago with sciatica-Occipit-atl-axl	0.001	0.999	0.000
M54.40 Lumbago with sciatica (Multiple sites in spine)	0.001	0.999	0.000
M89.19 Epiphyseal arrest (Site unspecified)	0.001	0.999	0.000
M89.18 Epiphyseal arrest (Other)	0.001	0.999	0.000
M89.17 Epiphyseal arrest (Ankle and foot)	0.001	0.999	0.000
M89.16 Epiphyseal arrest (Lower leg)	0.001	0.999	0.000
M89.15 Epiphyseal arrest (Pelvic region and thigh)	0.001	0.999	0.000
M89.14 Epiphyseal arrest (Hand)	0.001	0.999	0.000
M89.13 Epiphyseal arrest (Forearm)	0.001	0.999	0.000
M89.12 Epiphyseal arrest (Upper arm)	0.001	0.999	0.000
M89.11 Epiphyseal arrest (Shoulder region)	0.001	0.999	0.000
M89.10 Epiphyseal arrest (Multiple sites)	0.001	0.999	0.000
M89.29 Other disorders of bone development and growth (Site unspecified)	0.001	0.999	0.000
M89.28 Other disorders of bone development and growth (Other)	0.001	0.999	0.000
M89.27 Other disorders of bone development and growth (Ankle and foot)	0.001	0.999	0.000
M89.26 Other disorders of bone development and growth (Lower leg)	0.001	0.999	0.000
M89.25 Other disorders of bone development and growth (Pelvic region and thigh)	0.001	0.999	0.000
M89.24 Other disorders of bone development and growth (Hand)	0.001	0.999	0.000
M89.23 Other disorders of bone development and growth (Forearm)	0.001	0.999	0.000
M89.22 Other disorders of bone development and growth (Upper arm)	0.001	0.999	0.000
M89.21 Other disorders of bone development and growth (Shoulder region)	0.001	0.999	0.000
M89.20 Other disorders of bone development and growth (Multiple sites)	0.001	0.999	0.000
M89.39 Hypertrophy of bone (Site unspecified)	0.001	0.999	0.000
M89.36 Hypertrophy of bone (Lower leg)	0.001	0.999	0.000
M89.35 Hypertrophy of bone (Pelvic region and thigh)	0.001	0.999	0.000
M89.34 Hypertrophy of bone (Hand)	0.001	0.999	0.000
M89.33 Hypertrophy of bone (Forearm)	0.001	0.999	0.000
M89.32 Hypertrophy of bone (Upper arm)	0.001	0.999	0.000
M89.31 Hypertrophy of bone (Shoulder region)	0.001	0.999	0.000
M89.30 Hypertrophy of bone (Multiple sites)	0.001	0.999	0.000
M89.49 Other hypertrophic osteoarthropathy (Site unspecified)	0.001	0.999	0.000
M89.48 Other hypertrophic osteoarthropathy (Other)	0.001	0.999	0.000
M89.47 Other hypertrophic osteoarthropathy (Ankle and foot)	0.001	0.999	0.000
M89.46 Other hypertrophic osteoarthropathy (Lower leg)	0.001	0.999	0.000
M89.45 Other hypertrophic osteoarthropathy (Pelvic region and thigh)	0.001	0.999	0.000
M89.44 Other hypertrophic osteoarthropathy (Hand)	0.001	0.999	0.000
M89.43 Other hypertrophic osteoarthropathy (Forearm)	0.001	0.999	0.000
M89.42 Other hypertrophic osteoarthropathy (Upper arm)	0.001	0.999	0.000
M89.41 Other hypertrophic osteoarthropathy (Shoulder region)	0.001	0.999	0.000
M89.40 Other hypertrophic osteoarthropathy (Multiple sites)	0.001	0.999	0.000
M89.69 Osteopathy after poliomyelitis (Site unspecified)	0.001	0.999	0.000
M89.68 Osteopathy after poliomyelitis (Other)	0.001	0.999	0.000
M89.67 Osteopathy after poliomyelitis (Ankle and foot)	0.001	0.999	0.000
M89.66 Osteopathy after poliomyelitis (Lower leg)	0.001	0.999	0.000
M89.65 Osteopathy after poliomyelitis (Pelvic region and thigh)	0.001	0.999	0.000
M89.64 Osteopathy after poliomyelitis (Hand)	0.001	0.999	0.000
M89.63 Osteopathy after poliomyelitis (Forearm)	0.001	0.999	0.000
M89.62 Osteopathy after poliomyelitis (Upper arm)	0.001	0.999	0.000
M89.61 Osteopathy after poliomyelitis (Shoulder region)	0.001	0.999	0.000
M89.60 Osteopathy after poliomyelitis (Multiple sites)	0.001	0.999	0.000
S22.30 Fracture of rib (closed)	0.001	0.999	0.000
K92.0 Haematemesis	0.000	0.999	0.001
M67.2 Synovial hypertrophy, not elsewhere classified	0.000	0.999	0.001
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.001	0.999	0.000
N90.4 Leukoplakia of vulva	0.000	0.999	0.001
U89.8 Agent resistant to other single specified antibiotic	0.001	0.999	0.000
Y46.8 Antispasticity drugs	0.001	0.999	0.000
Y46.5 Valproic acid	0.001	0.999	0.000
Y46.3 Deoxybarbiturates	0.001	0.999	0.000
Y46.2 Hydantoin derivatives	0.001	0.999	0.000
Y46.1 Oxazolidinediones	0.001	0.999	0.000
Y46.0 Succinimides	0.001	0.999	0.000
D16 Benign neoplasm of bone and articular cartilage	0.000	0.999	0.001
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.001	0.999	0.000
B37.4 Candidiasis of other urogenital sites	0.001	0.999	0.000
M67.4 Ganglion	0.000	0.999	0.001
M67.1 Other contracture of tendon (sheath)	0.000	0.999	0.001
S66.2 Injury of extensor muscle and tendon of thumb at wrist and hand level	0.001	0.999	0.000
S66.0 Injury of long flexor muscle and tendon of thumb at wrist and hand level	0.001	0.999	0.000
Y44.5 Thrombolytic drugs	0.001	0.999	0.000
Y44.2 Anticoagulants	0.001	0.999	0.000
Y48.5 Therapeutic gases	0.001	0.999	0.000
Y48.1 Parenteral anaesthetics	0.001	0.999	0.000
Y48.0 Inhaled anaesthetics	0.001	0.999	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.001	0.999	0.000
Y54.8 Agents affecting uric acid metabolism	0.001	0.999	0.000
M89.59 Osteolysis (Site unspecified)	0.001	0.999	0.000
M89.58 Osteolysis (Other)	0.001	0.999	0.000
M89.57 Osteolysis (Ankle and foot)	0.001	0.999	0.000
M89.56 Osteolysis (Lower leg)	0.001	0.999	0.000
M89.54 Osteolysis (Hand)	0.001	0.999	0.000
M89.53 Osteolysis (Forearm)	0.001	0.999	0.000
M89.52 Osteolysis (Upper arm)	0.001	0.999	0.000
M89.51 Osteolysis (Shoulder region)	0.001	0.999	0.000
M89.50 Osteolysis (Multiple sites)	0.001	0.999	0.000
C77.0 Lymph nodes of head, face and neck	0.000	0.999	0.001
M67.9 Disorder of synovium and tendon, unspecified	0.000	0.999	0.001
M67.3 Transient synovitis	0.000	0.999	0.001
Y49.9 Psychotropic drug, unspecified	0.001	0.999	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
Y49.7 Psychostimulants with abuse potential	0.001	0.999	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.001	0.999	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.001	0.999	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.001	0.999	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.001	0.999	0.000
Y53.4 Other laxatives	0.001	0.999	0.000
C92 Myeloid leukaemia	0.001	0.999	0.000
W24 Contact with lifting and transmission devices, not elsewhere classified	0.001	0.999	0.000
Y59 Other and unspecified vaccines and biological substances	0.001	0.999	0.000
M67.43 Ganglion, wrist	0.000	0.999	0.001
D16.9 Bone and articular cartilage, unspecified	0.000	0.999	0.001
D16.8 Pelvic bones, sacrum and coccyx	0.000	0.999	0.001
D16.7 Ribs, sternum and clavicle	0.000	0.999	0.001
D16.6 Vertebral column	0.000	0.999	0.001
D16.5 Lower jaw bone	0.000	0.999	0.001
D16.2 Long bones of lower limb	0.000	0.999	0.001
I27.8 Other specified pulmonary heart diseases	0.001	0.999	0.000
N90.6 Hypertrophy of vulva	0.000	0.999	0.001
Y48.4 Anaesthetic, unspecified	0.001	0.999	0.000
Y59.3 Immunoglobulin	0.001	0.999	0.000
Y58 Bacterial vaccines	0.001	0.999	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.001	0.999	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.001	0.999	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.001	0.999	0.000
M67.49 Ganglion, multiple sites	0.000	0.999	0.001
M67.47 Ganglion, ankle and foot	0.000	0.999	0.001
M67.45 Ganglion, hip	0.000	0.999	0.001
M89.37 Hypertrophy of bone (Ankle and foot)	0.001	0.999	0.000
A02.0 Salmonella gastro-enteritis	0.001	0.999	0.000
X50.2 School, other institution and public administrative area	0.001	0.999	0.000
Y59.9 Vaccine or biological substance, unspecified	0.001	0.999	0.000
Y59.8 Other specified vaccines and biological substances	0.001	0.999	0.000
Y59.2 Protozoal vaccines	0.001	0.999	0.000
Y59.1 Rickettsial vaccines	0.001	0.999	0.000
Y59.0 Viral vaccines	0.001	0.999	0.000
Z50.1 Other physical therapy	0.000	0.999	0.001
M67.96 Unspecified disorder of synovium and tendon, lower leg	0.000	0.999	0.001
M89.55 Osteolysis (Pelvic region and thigh)	0.001	0.999	0.000
M89.81 Other specified disorders of bone (Shoulder region)	0.001	0.999	0.000
C92.9 Myeloid leukaemia, unspecified	0.001	0.999	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.001	0.999	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.001	0.999	0.000
C92.5 Acute myelomonocytic leukaemia	0.001	0.999	0.000
C92.3 Myeloid sarcoma	0.001	0.999	0.000
C92.2 Subacute myeloid leukaemia	0.001	0.999	0.000
M67.0 Short Achilles tendon (acquired)	0.000	0.999	0.001
O81.4 Vacuum extractor delivery	0.001	0.999	0.000
W24.8 Other specified place	0.001	0.999	0.000
W24.7 Farm	0.001	0.999	0.000
W24.6 Industrial and construction area	0.001	0.999	0.000
W24.5 Trade and service area	0.001	0.999	0.000
W24.4 Street and highway	0.001	0.999	0.000
W24.3 Sports and athletics area	0.001	0.999	0.000
W24.2 School, other institution and public administrative area	0.001	0.999	0.000
W24.1 Residential institution	0.001	0.999	0.000
W24.0 Home	0.001	0.999	0.000
W45.8 Other specified place	0.001	0.999	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.001	0.999	0.000
H10 Conjunctivitis	0.001	0.999	0.000
O16 Unspecified maternal hypertension	0.000	0.999	0.001
U89 Agent resistant to other and unspecified antibiotics	0.001	0.999	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.001	0.999	0.000
C92.4 Acute promyelocytic leukaemia	0.001	0.999	0.000
J01.9 Acute sinusitis, unspecified	0.000	0.999	0.001
S66.7 Injury of multiple extensor muscles and tendons at wrist and hand level	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations